BIOMAT Database Logo BIOMAT Database Logo

A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. 1995

M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
Second Department of Medicine, University of Helsinki, Finland.

OBJECTIVE Ursodeoxycholic acid (UDCA) and colchicine have beneficial effects in primary biliary cirrhosis (PBC). The efficacy of colchicine and UDCA in PBC was compared in a 2-year placebo-controlled study (n = 90). METHODS Clinical events, laboratory test results, and liver histology were recorded at the beginning and end of the trial. RESULTS There were significantly fewer dropouts for hepatic reasons with UDCA than with placebo. Pruritus was reduced by both active drugs. Colchicine improved liver function test results only modestly, whereas UDCA significantly decreased the serum activities of aminotransferases, alkaline phosphatase, and gamma-glutamyltransferase compared with colchicine and placebo. Serum total bilirubin levels were decreased only by UDCA. Both colchicine and UDCA reduced serum cholesterol levels, and UDCA also reduced high-density lipoprotein cholesterol levels. Furthermore, UDCA reduced the serum levels of immunoglobulin (Ig) M and IgG, and colchicine reduced IgG levels compared with placebo. The elevated serum level of aminoterminal propeptide of type III procollagen remained unchanged by colchicine or UDCA, whereas the serum level of carboxyterminal propeptide of type I procollagen was significantly decreased by UDCA. UDCA significantly decreased ductular proliferation compared with colchicine or placebo. CONCLUSIONS These data suggest that UDCA frequently is superior to colchicine and especially to placebo in the treatment of PBC.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer

Related Publications

M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
December 2000, Alimentary pharmacology & therapeutics,
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.
September 2001, Alimentary pharmacology & therapeutics,
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
[Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
March 1992, Zeitschrift fur Gastroenterologie,
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
September 1995, Hepatology (Baltimore, Md.),
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
[A case of primary biliary cirrhosis treated with colchicine and ursodeoxycholic acid].
October 1988, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis.
January 1992, Journal of gastroenterology and hepatology,
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
Colchicine and ursodeoxycholic acid for primary biliary cirrhosis: emerging results.
May 1995, Gastroenterology,
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
[Treatment of primary biliary cirrhosis with ursodeoxycholic acid].
January 2000, Vutreshni bolesti,
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
November 1996, Hepatology (Baltimore, Md.),
M Vuoristo, and M Färkkilä, and A L Karvonen, and R Leino, and J Lehtola, and J Mäkinen, and J Mattila, and C Friman, and K Seppälä, and J Tuominen
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.
November 1989, Gastroenterology,
Copied contents to your clipboard!